Please login to the form below

Not currently logged in
Email:
Password:

Cardio3 BioSciences

This page shows the latest Cardio3 BioSciences news and features for those working in and with pharma, biotech and healthcare.

The development of stem cell therapies

The development of stem cell therapies

Cardio3 BioSciences is developing C-Cure, a human adult bone marrow derived somatic cell therapy.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Pharma deals during January 2015 Pharma deals during January 2015

    In the same field but an asset acquisition, Cardio3 BioSciences bought the oncology division of Celdara Medical for a headline of $180m in a mix of cash, stock and royalties.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics